Pursuant to Notice of Board meeting dated 16th May 2025 the Board Meeting of the Company was held today Saturday, 24th May 2025 at 2.00 p.m. at 4th Floor, Sambava Chambers, Sir P. M. Road, ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Triochem Products approved the audited financial results for Q4 and the full year ended March 31, 2025. Total income for FY25 was Rs. 105.01 lakhs, marginally up from Rs. 102.96 lakhs in FY24, while the company reported a net loss of Rs. 40.01 lakhs (improved from a Rs. 101.33 lakh loss in FY24, which had absorbed a Rs. 115.65 lakh exceptional IGST interest charge). Q4 revenue fell sharply to Rs. 32.47 lakhs from Rs. 80.23 lakhs a year earlier. Management disclosed that operations have been temporarily scaled down post-Covid as relationship-driven business has not recovered and regular customers are shrinking, though it maintains the company has sufficient liquidity. The statutory auditor issued an unqualified opinion. The Board also fixed the 53rd AGM for June 25, 2025, approved the re-appointment of two directors, and appointed a new Secretarial Auditor for a five-year term and Internal Auditors for FY 2025-26.
Shareholders should note the company is operating at a minimal scale with persistent losses and shrinking activity, though liquidity is comfortable and losses have narrowed. The unqualified audit opinion and absence of dividend signal limited near-term prospects; the stock may remain thinly traded with sentiment pressured by the subdued operating outlook.